ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,686Medicare Part D Prescriptions Filled, Including Refills

Rank: 24 out of 198

$752K Total Retail Price of All Prescriptions

Rank: 23 out of 198

459 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
33% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 459 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

19% of this provider’s 459 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 12,058 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
HYDROCODONE-ACETAMINOPHEN 608 436 S3 1 8
POTASSIUM CHLORIDE 576 511 2 9
LEVOTHYROXINE SODIUM 522 437 3 1
OMEPRAZOLE 496 415 4 3
LISINOPRIL 482 414 5 6
METOPROLOL SUCCINATE 429 422 6 11
FUROSEMIDE 427 338 7 5
WARFARIN SODIUM 346 308 8 7
LOSARTAN POTASSIUM 301 271 9 18
AMLODIPINE BESYLATE 283 276 10 4
SERTRALINE HCL 200 160 11 25
SIMVASTATIN 194 180 12 2
HYDROCHLOROTHIAZIDE 191 191 13 16
SPIRONOLACTONE 184 142 14 37
CITALOPRAM HBR 176 153 15 20
ATENOLOL 170 161 16 17
GABAPENTIN 167 94 17 14
METOPROLOL TARTRATE 161 149 18 10
ZOLPIDEM TARTRATE 153 145 19 22
DIOVAN 144 131 20 34
DONEPEZIL HCL 139 128 21 28
METFORMIN HCL 127 124 22 13
LOVASTATIN 125 110 23 70
ALLOPURINOL 122 122 24 23
RANITIDINE HCL 119 91 25 54
VENLAFAXINE HCL ER 112 88 26 84
ATORVASTATIN CALCIUM 109 95 27 12
CYCLOBENZAPRINE HCL 105 76 R 28 67
SYNTHROID 104 92 29 36
PANTOPRAZOLE SODIUM 103 80 30 31
BENICAR 103 98 30 100
OXYBUTYNIN CHLORIDE ER 101 69 32 109
MIRTAZAPINE 101 88 32 44
FELODIPINE ER 98 98 34 163
TRAMADOL HCL 91 58 35 15
FLUTICASONE PROPIONATE 91 72 35 39
CYMBALTA 89 67 37 48
PREDNISONE 89 83 37 29
INSULIN SYRINGE 82 69 39 95
NEXIUM 81 68 40 40
SPIRIVA 81 81 40 63
LOSARTAN-HYDROCHLOROTHIAZIDE 81 81 40 49
MELOXICAM 79 79 43 30
CARVEDILOL 79 76 43 24
ACETAMINOPHEN-CODEINE 76 55 S3 45 135
OXYCODONE-ACETAMINOPHEN 74 28 S2 46 79
GLIMEPIRIDE 73 64 47 35
LANTUS 73 62 47 46
CLOPIDOGREL 72 63 49 42
ISOSORBIDE MONONITRATE ER 72 62 49 60
EVISTA 72 72 49 104
CEPHALEXIN 71 65 52 108
FAMOTIDINE 68 67 53 57
FLUOXETINE HCL 67 50 54 78
DIOVAN HCT 67 66 54 88
VERAPAMIL ER 67 46 54 117
CELEBREX 67 27 54 59
NAMENDA 66 54 58 33
FENTANYL 65 63 S2 59 73
HUMALOG 64 24 60 128
QUETIAPINE FUMARATE 63 13 61 76
AZITHROMYCIN 63 54 61 56
POLYETHYLENE GLYCOL 3350 60 51 63 41
GLIPIZIDE ER 60 52 63 83
ISOSORBIDE DINITRATE 59 42 65 265
LISINOPRIL-HYDROCHLOROTHIAZIDE 59 59 65 38
AMITRIPTYLINE HCL 58 49 R 67 69
MORPHINE SULFATE ER 58 43 S2 67 160
DILTIAZEM 24HR CD 55 54 69 126
CRESTOR 55 50 69 26
TRIAMTERENE-HCTZ 53 53 71 32
PRAVASTATIN SODIUM 52 49 72 19
NOVOLOG 52 51 72 107
OXCARBAZEPINE 52 0 72 282
COUMADIN 51 51 75 221
ADVAIR DISKUS 51 49 75 47
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 13, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.